US Stock MarketDetailed Quotes

BNTX BioNTech

Watchlist
  • 119.790
  • +1.250+1.05%
Trading Nov 27 12:42 ET
28.72BMarket Cap-58864P/E (TTM)

BioNTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-178.76%-638.9M
-62.91%1.63B
53.16%-317.3M
-60.44%5.37B
2.62%850.9M
-83.03%811.2M
11.93%4.39B
-116.73%-677.4M
1,426.06%13.58B
515.64%829.2M
Net income from continuing operations
-30.21%158.7M
-95.49%-805.8M
-146.88%-331.8M
-90.84%1.19B
-79.10%663.2M
-90.70%227.4M
-117.77%-412.2M
-85.90%707.7M
-13.91%12.95B
-32.70%3.17B
Operating gains losses
-101.46%-41.5M
96.92%-8.4M
-120.85%-27M
-130.82%-118.7M
-91.37%45.3M
-118.05%-20.6M
-5.82%-272.9M
2,983.33%129.5M
218.27%385.1M
1,047.11%524.7M
Depreciation and amortization
7.51%44.4M
56.43%49.9M
21.97%38.3M
48.74%183.4M
171.72%78.8M
23.28%41.3M
-3.92%31.9M
13.77%31.4M
63.96%123.3M
11.54%29M
Other non cash items
-58.73%-239.2M
10.60%-140M
78.70%-172.5M
-328.16%-1.28B
-89.70%-158.4M
-2,854.90%-150.7M
-7,557.14%-156.6M
-281.26%-809.8M
-249.62%-297.9M
-1,310.14%-83.5M
Change In working capital
-205.61%-675.3M
-49.72%2.37B
366.46%222.5M
23.38%5.57B
112.47%182.8M
-77.83%639.4M
80.73%4.7B
-90.41%47.7M
142.11%4.52B
-0.45%-1.47B
-Change in receivables
-231.53%-830.2M
-61.33%1.6B
-44.26%498.2M
22.98%5.37B
55.47%-288M
-71.89%631.2M
30.31%4.14B
321.51%893.8M
137.01%4.37B
62.24%-646.8M
-Change in inventory
11.45%37M
121.37%5.3M
-20.65%12.3M
30.21%81.9M
140.06%58M
-54.46%33.2M
-127.07%-24.8M
-64.12%15.5M
114.35%62.9M
-32.72%-144.8M
-Change in payables and accrued expense
571.60%117.9M
28.36%760.8M
66.57%-288M
38.74%118.9M
161.19%412.8M
-104.42%-25M
189.38%592.7M
-200.48%-861.6M
-94.35%85.7M
-286.25%-674.6M
Cash from discontinued investing activities
Operating cash flow
-178.76%-638.9M
-62.91%1.63B
53.16%-317.3M
-60.44%5.37B
2.62%850.9M
-83.03%811.2M
11.93%4.39B
-116.73%-677.4M
1,426.06%13.58B
515.64%829.2M
Investing cash flow
Cash flow from continuing investing activities
88.47%-142.1M
89.47%-241.4M
-213.35%-2.3B
-19,601.13%-6.95B
-1,573.98%-2.7B
-1,379.23%-1.23B
-2,823.21%-2.29B
-355.88%-735.4M
93.76%-35.3M
-61.16%-161M
Net PPE purchase and sale
-34.26%-72.5M
-31.55%-88.4M
-29.42%-58.5M
23.89%-250.1M
38.64%-83.7M
30.32%-54M
4.82%-67.2M
-2.49%-45.2M
-164.79%-328.6M
-264.71%-136.4M
Net intangibles purchase and sale
89.51%-10.2M
78.23%-52.7M
-716.67%-78.4M
-1,235.48%-455.4M
-1,248.10%-106.5M
-1,968.09%-97.2M
-4,943.75%-242.1M
42.51%-9.6M
-28.68%-34.1M
43.57%-7.9M
Net business purchase and sale
--0
----
----
---336.9M
--0
---336.9M
----
----
--0
--0
Net investment purchase and sale
92.02%-59.4M
94.94%-100.3M
-218.47%-2.17B
-1,905.77%-5.91B
-14,899.40%-2.5B
-67,545.45%-744.1M
-65,983.33%-1.98B
-295.46%-680.6M
182.95%327.4M
39.71%-16.7M
Cash from discontinued investing activities
Investing cash flow
88.47%-142.1M
89.47%-241.4M
-213.35%-2.3B
-19,601.13%-6.95B
-1,573.98%-2.7B
-1,379.23%-1.23B
-2,823.21%-2.29B
-355.88%-735.4M
93.76%-35.3M
-61.16%-161M
Financing cash flow
Cash flow from continuing financing activities
97.46%-7.9M
85.99%-22.9M
97.32%-7.8M
45.14%-778.6M
80.06%-12.9M
52.40%-311M
79.09%-163.4M
-462.76%-291.3M
-1,606.69%-1.42B
-32.31%-64.7M
Net issuance payments of debt
15.05%-7.9M
-143.62%-22.9M
16.13%-7.8M
32.15%-40.1M
-34.44%-12.1M
3.13%-9.3M
8.74%-9.4M
69.21%-9.3M
11.39%-59.1M
81.60%-9M
Net common stock issuance
--0
--0
--0
15.69%-738.5M
98.56%-800K
53.14%-301.7M
46.32%-154M
-355.20%-282M
-644.38%-875.9M
---55.7M
Cash dividends paid
----
----
----
--0
----
----
----
----
---484.3M
--0
Cash from discontinued financing activities
Financing cash flow
97.46%-7.9M
85.99%-22.9M
97.32%-7.8M
45.14%-778.6M
80.06%-12.9M
52.40%-311M
79.09%-163.4M
-462.76%-291.3M
-1,606.69%-1.42B
-32.31%-64.7M
Net cash flow
Beginning cash position
-26.75%10.38B
-26.08%8.98B
-15.94%11.66B
719.70%13.88B
0.54%13.5B
51.76%14.17B
97.01%12.14B
719.70%13.88B
39.87%1.69B
562.67%13.42B
Current changes in cash
-7.77%-788.9M
-29.44%1.36B
-54.30%-2.63B
-119.48%-2.36B
-407.72%-1.86B
-118.11%-732M
-36.86%1.93B
-138.57%-1.7B
2,801.58%12.12B
273.27%603.5M
Effect of exchange rate changes
-39.87%36.8M
-59.21%37.2M
-112.55%-57.6M
152.18%150.3M
116.44%25M
31.05%61.2M
-18.21%91.2M
-150.65%-27.1M
-7.88%59.6M
-1,094.12%-152.1M
End cash Position
-28.68%9.62B
-26.75%10.38B
-26.08%8.98B
-15.94%11.66B
-15.94%11.66B
0.54%13.5B
51.76%14.17B
97.01%12.14B
719.70%13.88B
719.70%13.88B
Free cash flow
-209.38%-721.9M
-63.56%1.49B
37.97%-454.2M
-64.69%4.67B
-3.51%660.7M
-85.95%660M
6.08%4.08B
-118.35%-732.2M
1,696.13%13.21B
370.74%684.7M
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -178.76%-638.9M-62.91%1.63B53.16%-317.3M-60.44%5.37B2.62%850.9M-83.03%811.2M11.93%4.39B-116.73%-677.4M1,426.06%13.58B515.64%829.2M
Net income from continuing operations -30.21%158.7M-95.49%-805.8M-146.88%-331.8M-90.84%1.19B-79.10%663.2M-90.70%227.4M-117.77%-412.2M-85.90%707.7M-13.91%12.95B-32.70%3.17B
Operating gains losses -101.46%-41.5M96.92%-8.4M-120.85%-27M-130.82%-118.7M-91.37%45.3M-118.05%-20.6M-5.82%-272.9M2,983.33%129.5M218.27%385.1M1,047.11%524.7M
Depreciation and amortization 7.51%44.4M56.43%49.9M21.97%38.3M48.74%183.4M171.72%78.8M23.28%41.3M-3.92%31.9M13.77%31.4M63.96%123.3M11.54%29M
Other non cash items -58.73%-239.2M10.60%-140M78.70%-172.5M-328.16%-1.28B-89.70%-158.4M-2,854.90%-150.7M-7,557.14%-156.6M-281.26%-809.8M-249.62%-297.9M-1,310.14%-83.5M
Change In working capital -205.61%-675.3M-49.72%2.37B366.46%222.5M23.38%5.57B112.47%182.8M-77.83%639.4M80.73%4.7B-90.41%47.7M142.11%4.52B-0.45%-1.47B
-Change in receivables -231.53%-830.2M-61.33%1.6B-44.26%498.2M22.98%5.37B55.47%-288M-71.89%631.2M30.31%4.14B321.51%893.8M137.01%4.37B62.24%-646.8M
-Change in inventory 11.45%37M121.37%5.3M-20.65%12.3M30.21%81.9M140.06%58M-54.46%33.2M-127.07%-24.8M-64.12%15.5M114.35%62.9M-32.72%-144.8M
-Change in payables and accrued expense 571.60%117.9M28.36%760.8M66.57%-288M38.74%118.9M161.19%412.8M-104.42%-25M189.38%592.7M-200.48%-861.6M-94.35%85.7M-286.25%-674.6M
Cash from discontinued investing activities
Operating cash flow -178.76%-638.9M-62.91%1.63B53.16%-317.3M-60.44%5.37B2.62%850.9M-83.03%811.2M11.93%4.39B-116.73%-677.4M1,426.06%13.58B515.64%829.2M
Investing cash flow
Cash flow from continuing investing activities 88.47%-142.1M89.47%-241.4M-213.35%-2.3B-19,601.13%-6.95B-1,573.98%-2.7B-1,379.23%-1.23B-2,823.21%-2.29B-355.88%-735.4M93.76%-35.3M-61.16%-161M
Net PPE purchase and sale -34.26%-72.5M-31.55%-88.4M-29.42%-58.5M23.89%-250.1M38.64%-83.7M30.32%-54M4.82%-67.2M-2.49%-45.2M-164.79%-328.6M-264.71%-136.4M
Net intangibles purchase and sale 89.51%-10.2M78.23%-52.7M-716.67%-78.4M-1,235.48%-455.4M-1,248.10%-106.5M-1,968.09%-97.2M-4,943.75%-242.1M42.51%-9.6M-28.68%-34.1M43.57%-7.9M
Net business purchase and sale --0-----------336.9M--0---336.9M----------0--0
Net investment purchase and sale 92.02%-59.4M94.94%-100.3M-218.47%-2.17B-1,905.77%-5.91B-14,899.40%-2.5B-67,545.45%-744.1M-65,983.33%-1.98B-295.46%-680.6M182.95%327.4M39.71%-16.7M
Cash from discontinued investing activities
Investing cash flow 88.47%-142.1M89.47%-241.4M-213.35%-2.3B-19,601.13%-6.95B-1,573.98%-2.7B-1,379.23%-1.23B-2,823.21%-2.29B-355.88%-735.4M93.76%-35.3M-61.16%-161M
Financing cash flow
Cash flow from continuing financing activities 97.46%-7.9M85.99%-22.9M97.32%-7.8M45.14%-778.6M80.06%-12.9M52.40%-311M79.09%-163.4M-462.76%-291.3M-1,606.69%-1.42B-32.31%-64.7M
Net issuance payments of debt 15.05%-7.9M-143.62%-22.9M16.13%-7.8M32.15%-40.1M-34.44%-12.1M3.13%-9.3M8.74%-9.4M69.21%-9.3M11.39%-59.1M81.60%-9M
Net common stock issuance --0--0--015.69%-738.5M98.56%-800K53.14%-301.7M46.32%-154M-355.20%-282M-644.38%-875.9M---55.7M
Cash dividends paid --------------0-------------------484.3M--0
Cash from discontinued financing activities
Financing cash flow 97.46%-7.9M85.99%-22.9M97.32%-7.8M45.14%-778.6M80.06%-12.9M52.40%-311M79.09%-163.4M-462.76%-291.3M-1,606.69%-1.42B-32.31%-64.7M
Net cash flow
Beginning cash position -26.75%10.38B-26.08%8.98B-15.94%11.66B719.70%13.88B0.54%13.5B51.76%14.17B97.01%12.14B719.70%13.88B39.87%1.69B562.67%13.42B
Current changes in cash -7.77%-788.9M-29.44%1.36B-54.30%-2.63B-119.48%-2.36B-407.72%-1.86B-118.11%-732M-36.86%1.93B-138.57%-1.7B2,801.58%12.12B273.27%603.5M
Effect of exchange rate changes -39.87%36.8M-59.21%37.2M-112.55%-57.6M152.18%150.3M116.44%25M31.05%61.2M-18.21%91.2M-150.65%-27.1M-7.88%59.6M-1,094.12%-152.1M
End cash Position -28.68%9.62B-26.75%10.38B-26.08%8.98B-15.94%11.66B-15.94%11.66B0.54%13.5B51.76%14.17B97.01%12.14B719.70%13.88B719.70%13.88B
Free cash flow -209.38%-721.9M-63.56%1.49B37.97%-454.2M-64.69%4.67B-3.51%660.7M-85.95%660M6.08%4.08B-118.35%-732.2M1,696.13%13.21B370.74%684.7M
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+1.33%